scorpion
- 13 Aug 2003 13:54
Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.
Bones
- 08 Feb 2004 14:22
- 66 of 2372
AdieH - RNS - (EDIT - thanks to publess for correction): Regulatory News Service - which supply the official Stock Exchange announcements, I believe is the term!
Bones
- 08 Feb 2004 14:23
- 67 of 2372
I read a quote from the BPRG CEO that the FMC deal was very complicated, hence the delay in announcing it. The inference was that the next deal (and more) is a bit more straightforward.
So, I am hoping for the OTC deal to emerge in the next week or two. It will be a big name so I hope they can say who. It is for exclusive use of another of BPRG's technologies covering the USA and the EU only. It entails the OTC company to build a film plant in the USA which will then also be availble to service BPRG's other US customers. BPRG have already said they are talking big numbers (in the RNS in November)
This leaves deals for non-USA/EU territories for that same technology to be done. It leaves the other two technologies to be commercialised. There is also ostomy which is already licenced to Bristol Myers Squibb and the product should roll this year.
All exciting because you have seen what "completed deal" and a big name and figures does to the share price and stirs the newspapers into action.
The good thing is the share price often moves slowly at first after the announcement. After FMC, you could have picked up BPRG in the early 80p area for a good couple of hours after the open (up only a few pence). You don't have to risk all on the hope of something. You can wait for the announcement and move quickly on the open!
But, as always, Do Your Own Research!
publess
- 08 Feb 2004 15:18
- 68 of 2372
--> Bones/ AdieH
Don't mean to be picky, but it's the Regulatory News Service - Reuters is another thing entirely.
One place to go for news is:
http://www.uk-wire.com/
goldfinger
- 09 Feb 2004 09:17
- 69 of 2372
This is the one to have your money on, comment from Killick one of my brokers and yes the BIG NEW contract is imminent any day now. I will let you know, had to check out no last minute problems but there arent, ITS MASSIVE, and I mean MASSIVE. Added a 'warehouse full' this morning after the confirmation.
Anyway heres thr brokers note...........
Following on from our comment on Bioprogress yesterday, we were able to hold
conversations with company management and representatives. The contract
announced which, they estimate could be worth around $160 million over six years,
looks to be conservative, but sticking with that for the time being, they are talking about
the machinery components of the contract (which will be manufactured by the world
leader in this area) being worth a gross profit of a minimum of 35% and the royalty
stream being significantly higher. With a low operating overhead which will not need
expanding far, this contract alone has the ability to support the current valuation. We
suspect others will follow shortly. The stock is seeing good two way business at around
1 a share where the company value is 100 million. Once the selling dries up, we see
a the stock well set for a further significant move to the upside.
cheers GF.
nematode
- 09 Feb 2004 09:39
- 70 of 2372
Any day now.will have to top up on any tree shake today by mm!!!Thanks GF,as ever very efficient.Hope the break in Spain has re-invigorated you.
Bones
- 09 Feb 2004 09:46
- 71 of 2372
publess, shows what I know!. Thanks.
Bones
- 09 Feb 2004 09:50
- 72 of 2372
GF - take a look at BIP when you get a chance. More blue-sky than BPRG but phenomenal potential in Vialogy. There are quite a few BPRG supporters in it now. I have a thread running:
http://www.moneyam.com/InvestorsRoom/ShowPostList?fID=1&tID=1991
goldfinger
- 09 Feb 2004 10:14
- 73 of 2372
Cheers Bones will have a look but have to say if I could put down on this board what I know about BPRG we would be looking at a bagger in 30mins time and thats true. Its mind blowing the potential and as you know Im a conservative type of chap I just feel so frustrated, by copywrite etc , etc.
Anyway have a good day my freind, sorry dont mean to harp on so much.
cheers GF.
nematode
- 09 Feb 2004 10:16
- 74 of 2372
It's already started GF,good on yer mate.Anymore news on RNS!!!!
nematode
- 09 Feb 2004 12:30
- 75 of 2372
MM's drop price results in a surge of buying.Why do people sell when we're so close to a rns.GF any ideas???You seem very quiet for such a bullish stock!
binman
- 09 Feb 2004 13:18
- 76 of 2372
nematode
- 09 Feb 2004 18:22
- 77 of 2372
Seem strange that GF disappears when u most need him?????
Janus
- 09 Feb 2004 18:43
- 78 of 2372
Exiting times to come on this one methinks 1/3 week timescale IMHO
ssanebs
- 10 Feb 2004 15:51
- 79 of 2372
spoke to graham hind who said that the us deal will be announced at the end of the month due to all the legalities of the deal which are vast. The fmc deal was seen as more important to announce first.
goldfinger
- 11 Feb 2004 11:53
- 80 of 2372
Dont forget this one, new contract awaits.
GF.
nematode
- 11 Feb 2004 20:24
- 81 of 2372
When r we due contract ie the otc deal gf???
goldfinger
- 11 Feb 2004 20:59
- 82 of 2372
nematode how do I contact you on this site?. No e-mail or private message facility.?. sorry a bit lost here. Can you please advice?.
cheers GF.
Janus
- 12 Feb 2004 07:47
- 83 of 2372
Taken from another board re shares mag write up
New deal sweetens the pill for Bioprogress
Further deals are in the offing at Bioprogress (AIM:BPRG) after it signed a major agreement for its film encapsulation technology NROBE.
Shares in the company rocketed 36% to 106p after management announced a licensing deal worth $160 million with US company FMCCorporation.
Bioprogress designs biodegradable encapsulation systems for pharmaceutical tablets. Its technology replaces beef-derived gelatin encapsulation, which experts fear could carry CJD.
The film could help pharmaceutical companies facing generic competition launch new versions of existing products.
Chemical company FMC has secured an exclusive global licence for Bioprogresss NROBE dosage technology and is responsible for commercialising it. FMC must buy a minimum number of Bioprogresss encapsulation machines over the first six years and at least 50% of its film requirement over the next three years.
This is a terrific deal for us and has a big impact on what were doing, says chief executive Graham Hind. As a small company we need to have a partner that has worked with pharmaceutical companies for a long time. FMC is not interested in anything that isnt going to make billions. Its set up a separate division just for this.
Hind claims that there are more deals on the way and is considering hitting the acquisition trail.
People should understand this is one of several more deals coming down the pipeline, says Hind. Its not just a flash in the pan. Plus we have a liquid stock and this gives me the opportunity of considering acquisitions.
Speculative buy.
goldfinger
- 12 Feb 2004 09:37
- 84 of 2372
Excelent post Janus.
cheers Gf.
nematode
- 12 Feb 2004 12:01
- 85 of 2372
gf if you click on nematode then you can send a message on.